American Medical Technologies Inc.
ADLI · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.00 | -0.63 | -0.02 |
| FCF Yield | -2.60% | 3.00% | -8.13% | -6.55% |
| EV / EBITDA | -50.75 | -617.91 | -12.13 | -24.46 |
| Quality | ||||
| ROIC | 11.44% | 15.31% | 46.77% | 47.87% |
| Gross Margin | 63.67% | 67.41% | 69.76% | 53.88% |
| Cash Conversion Ratio | 0.32 | 0.22 | -19.60 | -0.76 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.14% | 10.97% | 13.68% | 13.87% |
| Free Cash Flow Growth | -211.48% | 137.34% | 22.01% | -70.28% |
| Safety | ||||
| Net Debt / EBITDA | -17.32 | -248.22 | -4.09 | -5.19 |
| Interest Coverage | 8.39 | 4.79 | 20.26 | 12.21 |
| Efficiency | ||||
| Inventory Turnover | 1.51 | 1.65 | 1.30 | 2.45 |
| Cash Conversion Cycle | -178.63 | -213.07 | -242.78 | -113.62 |